Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. E. Meijer

Speerpunten

Esther Meijer is internist-nefroloog met specifieke interesse in Autosomaal Dominante Polycysteuze nierziekte (in de volksmond 'cystenieren'). Ze doet zowel klinisch werk als onderzoek. Op een speciale cystenierpoli en in supervisie ziet ze ongeveer 300 cystenierpatienten per jaar. Ze coordineert een landelijk observationeel cysteniercohort. Haar huidige onderzoek gaat over markesr voor ziekteprogressie en behandeling van ADPKD. In 2019 ontving ze een subsidie van de Nierstichting

 

Publicaties

Caught Between Now and Next: A Qualitative Study into Final-Year Medical Students' Clerkship Choices

Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140

Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN

Family Planning in Patients With ADPKD–Results From the DIPAK Consortium

In Reply to "Kidney Cysts in Alport Syndrome: Illustrative Cases, but Misleading Conclusions"

Kidney Cysts in Autosomal Dominant Polycystic Kidney Disease and Alport Syndrome: Two Familial Cases Illustrating Diagnostic Challenges

Predicting Kidney Outcomes in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Biomarker Analysis

Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD

The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD

Effects of salt and protein intake on polyuria in V2RA-treated ADPKD patients